IDSA/ATS criteria | Subjects | MV/VS | 30-day mortality | ||||||
Needed# | Not needed¶ | OR (95% CI) | p-value | Deaths+ | Survivors§ | OR (95% CI) | p-value | ||
Hypoglycaemiaƒ <4.4 mmol·L−1 | 46 (4.3) | 15 (21.4) | 31 (3.1) | 8.45 (4.3–16.6) | <0.0001 | 9 (18.8) | 39 (3.8) | 5.77 (2.61–12.7) | <0.0001 |
Hyperglycaemia >14 mmol·L−1 | 24 (2.3) | 3 (4.3) | 21 (2.1) | 2.07 (0.60–7.12) | 0.2 | 4 (8.3) | 20 (2.0) | 4.52 (1.48–13.8) | 0.004 |
Hyponatraemia <130 mmol·L−1 | 90 (8.5) | 11 (15.7) | 79 (8.0) | 2.15 (1.09–4.27) | 0.02 | 9 (18.8) | 81 (8.0) | 2.66 (1.24–5.68) | 0.009 |
Acidosis pH <7.35 | 112 (10.5) | 28 (40) | 84 (8.5) | 7.21 (4.25–12.2) | <0.0001 | 27 (56.3) | 85 (8.4) | 14.1 (7.6–25.9) | <0.0001 |
Acute alcohol ingestion/withdrawal | 48 (4.5) | 2 (2.9) | 46 (4.6) | 0.60 (0.14–2.54) | 0.5 | 1 (2.1) | 47 (4.6) | 0.44 (0.06–3.24) | 0.4 |
Liver cirrhosis/chronic liver disease | 34 (3.2) | 3 (4.3) | 31 (3.1) | 1.39 (0.41–4.66) | 0.6 | 4 (8.3) | 30 (3.0) | 2.98 (1.01–8.83) | 0.04 |
Asplenia | 6 (0.6) | 1 (1.4) | 5 (0.5) | 2.86 (0.33–24.8) | 0.3 | 1 (2.1) | 5 (0.5) | 4.29 (0.49–37.5) | 0.2 |
Data are presented as n (%), unless otherwise stated. MV/VS: mechanical ventilation/vasopressor. #: n=70; ¶: n=992; +: n=48; §: n=1014; ƒ: in nondiabetic patients.